Publications by authors named "Boris K Lin"

Claim this Profile
C
CNS Protective Effect of Selpercatinib in First-Line Fusion-Positive Advanced Non-Small Cell Lung Cancer.
Maurice Pérol, Benjamin J Solomon, Koichi Goto, Keunchil Park, Ernest Nadal, Boris K Lin

J Clin Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Selpercatinib or Chemotherapy and Pembrolizumab in Fusion-Positive NSCLC.
Caicun Zhou, Benjamin Solomon, Herbert H Loong, Keunchil Park, Maurice Pérol, Nalin Payakachat, A Bence Lin, Boris K Lin

N Engl J Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer.
Christopher J Sweeney, Ivor J Percent, Sunil Babu, Jennifer L Cultrera, Bryan A Mehlhaff, Boris Kin Lin

Clin Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III study of selpercatinib versus chemotherapy ± pembrolizumab in untreated positive non-small-cell lung cancer.
Benjamin J Solomon, Cai Cun Zhou, Alexander Drilon, Keunchil Park, Jürgen Wolf, Aimee Bence Lin, Boris K Lin

Future Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial.
Talia Golan, Ravit Geva, Donald Richards, Srinivasan Madhusudan, Boris Kin Lin

J Cachexia Sarcopenia Muscle· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, phase 2 study of R-CHOP plus enzastaurin vs R-CHOP in patients with intermediate- or high-risk diffuse large B-cell lymphoma.
John D Hainsworth, Edward R Arrowsmith, Michael McCleod, Eric D Hsi, Oday Hamid, Boris K Lin

Leuk Lymphoma· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myostatin Neutralization Results in Preservation of Muscle Mass and Strength in Preclinical Models of Tumor-Induced Muscle Wasting.
Rosamund C Smith, Martin S Cramer, Pamela J Mitchell, Andrew Capen, Lysiane Huber, Boris K Lin

Mol Cancer Ther· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-label, single-arm, phase II study of enzastaurin in patients with follicular lymphoma.
Lee Schwartzberg, Robert Hermann, Ian Flinn, Douglas Flora, Eric D Hsi, Boris K Lin, Martin Dreyling

Br J Haematol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders.
Rosamund C Smith, Boris K Lin

Curr Opin Support Palliat Care· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of pemetrexed in patients with relapsed or refractory acute leukemia.
Isam Abdel-Karim, William K Plunkett, Susan O'Brien, Francis Giles, Deborah Thomas, Boris K Lin

Invest New Drugs· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting PKC: a novel role for beta-catenin in ER stress and apoptotic signaling.
Marc S Raab, Iris Breitkreutz, Giovanni Tonon, Jing Zhang, Patrick J Hayden, Boris K Lin

Blood· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting PKC in multiple myeloma: in vitro and in vivo effects of the novel, orally available small-molecule inhibitor enzastaurin (LY317615.HCl).
Klaus Podar, Marc S Raab, Jing Zhang, Douglas McMillin, Iris Breitkreutz, Boris K Lin

Blood· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective analysis of protein kinase C-beta (PKC-beta) expression in lymphoid malignancies and its association with survival in diffuse large B-cell lymphomas.
Shuyu Li, Mark Phong, Michael Lahn, Leslie Brail, Susan Sutton, Boris K Lin

Biol Direct· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activation.
Klaus Podar, Yu-Tzu Tai, Boris K Lin, Radha P Narsimhan, Martin Sattler

J Biol Chem· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis